 | Passage Bio, Inc. | |||
| NMS : PASG || Location: United States | ||||
$1.23+0.09 (+7.89%) |
0.05 M | 1.1 - 1.26 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.322 M |
| March 15, 2024 | 1.212 M |
| Feb. 29, 2024 | 0.558 M |
| Feb. 15, 2024 | 0.251 M |
| Jan. 31, 2024 | 0.278 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.41 | -0.30 | 26.79% |
| 09/30/2023 | -0.47 | -0.49 | -5.31% |
| 06/30/2023 | -0.49 | -0.44 | 9.82% |
| 03/31/2023 | -0.51 | -0.63 | -24.70% |
| 12/31/2022 | -0.53 | -0.49 | 8.10% |
PASG Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 61.612M | Shares Float | 37.412M |
| Short Float | 1.322M | Market Cap | 70.24M |
| Institution ownership | 55.75% | Insider ownership | 0.320% |
| Earnings Date | 05/13/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.86 | Forward EPS | -0.94 |